Press release
July 13, 2026
Erasca Announces Proposed Public Offering of $500 Million of Common Stock
Erasca, Inc. (ERAS)
SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell,